, Volume 88, Issue 2, pp 237–239 | Cite as

Studies with {α2}-adrenoceptor agonists and alcohol abstinence syndrome in rats

  • Milind P. Parale
  • S. K. Kulkarni
Original Investigations


Various α2-adrenoceptor agonists were assessed for their effects on alcohol abstinence syndrome in rats. In the first experimental model, groups of Wistar rats were made alcohol dependent by feeding alcohol together with sweetened milk for 15 days. The volume of fluid intake was measured every 12 h to determine daily ethanol consumption. Abstinence signs following abrupt alcohol withdrawal were observed in control as well as test groups receiving various α2-adrenoceptor agonists. Clonidine, guanfacine and B-HT 920, in equimolar concentration (0.5 μM/kg), effectively attenuated the various abstinence signs, which developed after alcohol withdrawal. In the other experimental model, rats were subjected to cold water immersion to induce wet shakes. The inhibitory action of α2-adrenoceptor agonists was assessed in this test model. Clonidine, guanfacine and B-HT 920 markedly suppressed the cold water immersion-induced wet shakes and pretreatment with yohimbine (0.1 and 2.0 μM/kg) reversed this inhibitory effect. The present data reveal the possible therapeutic potential of α2-adrenoceptor agonists in alleviating alcohol abstinence syndrome, and suggest that the resultant reduced noradrenergic activity may be responsible for the beneficial action.

Key words

B-HT 920 Guanfacine Yohimbine Naloxone Clonidine Alcohol withdrawal 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anden NE, Gabrowska M, Strombom U (1976) Different alpha adrenoceptors in the central nervous system mediating the biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedebergs Arch Pharmacol 292:43–52Google Scholar
  2. Bjorkqvist SE (1975) Clonidine in alcohol withdrawal. Acta Psychiatr Scand 52:256–263Google Scholar
  3. Borg S, Kvande H, Mossberg D, Sedvall G (1983) Central nervous noradrenaline metabolism in alcoholics during long-term abstinence. Alcohol and Alcoholism 18:321–323Google Scholar
  4. Dausse JP, Cardot A, Meyer P (1983) Specific binding of3H-guanfacine to alpha2 adrenceptors in rat brain: comparison with clonidine. J Pharmacol Paris 14:35–46Google Scholar
  5. Drew GM, Gower AJ, Marriott AS (1979) Alpha2 adrenoceptors mediate clonidine induced sedation in the rat. Br J Pharmacol 67:133–142Google Scholar
  6. Franz DN, Hare BD, McCloskey KL (1982) Spinal sympathetic neurones: possible sites of opiate-withdrawal suppression by clonidine. Science 215:1643–1645Google Scholar
  7. Freedman R, Kirch D, Bell J, Adler LE, Pecevich M, Pachtman E, Denver P (1982) Clonidine treatment of schizophrenia. Double blind comparison to placebo and neuroleptic drugs. Acta Psychiatr Scand 65:35–45Google Scholar
  8. Gold MS, Redmond DE, Kleber HD (1978) Clonidine in opiate withdrawal. Lancet 1:929Google Scholar
  9. Kobinger W, Pichler L (1981) α1- and β2-adrenoceptor subtypes: Selectivity of various agonists and relative distribution of receptors as determined in rats. Eur J Pharmacol 73:313–321Google Scholar
  10. Koss MC (1981) Analysis of pupillary dilation produced by analogs of clonidine. Eur J Pharmacol 74:303–309Google Scholar
  11. Kulkarni SK (1980) Apomorphine hypothermia: Interaction with serotonergic agents. Pol J Pharmacol Pharm 32:15–20Google Scholar
  12. Kulkarni SK, Mehta AK, Kunchandy J (1984) Some non-cardiovascular actions of clonidine. Drugs of Today 20:497–507Google Scholar
  13. Maj J, Sowinska H, Baran L, Kapturkiewicz Z (1972) The effect of clonidine on locomotor activity in mice. Life Sci 11:483–491Google Scholar
  14. Maj J, Baran L, Sowinska H, Zielinski M (1975) The influence of cholinolytics on clonidine action. Pol J Pharmacol 27:17–26Google Scholar
  15. Martin WR, Wikler A, Bades CG, Pescor FT (1963) Tolerance to and physical dependence on morphine in rats. Psychopharmacologia 4:247–260Google Scholar
  16. Mottram DR (1983) Pre-junctionalα 2-adrenoceptor activity of B-HT 920. J Pharm Pharmacol 35:652–655Google Scholar
  17. Silverman AP (1965) Ethological and statistical analysis of drug effects on the social behaviour of laboratory rats. Br J Pharmacol 24:579–590Google Scholar
  18. Starke K, Borowski E, Endo T (1975) Preferential blockade of presynaptic alpha adrenoceptors by yohimbine. Eur J Pharmacol 34:385–388Google Scholar
  19. Strombom U, Svensson T, Carlsson A (1977) Antagonism of Ethanol's central stimulation in mice by small doses of catecholamine-receptor agonists. Psychopharmacology 51:293–299Google Scholar
  20. Van Der Laan JW, Van Veenendaal W, Voorthuis P, Weick G, Hillen FC (1985) The effects of centrally acting adrenergic agonists on temperature and on explorative and motor behaviour. Relation with effects on quasi-morphine withdrawal behaviour. Eur J Pharmacol 107:367–373Google Scholar
  21. Wei E, Loh HH, Way EL (1973) Neuroanatomical correlates of wet shake behaviour in the rat. Life Sci 12:489–496Google Scholar
  22. Wilkins AJ, Jenkins WJ, Steiner JA (1983) Efficacy of clonidine in treatment of alcohol withdrawal state. Psychopharmacology 81:78–80Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • Milind P. Parale
    • 1
  • S. K. Kulkarni
    • 1
  1. 1.Pharmacology Division, Department of Pharmaceutical SciencesPanjab UniversityChandigarhIndia

Personalised recommendations